Open AccessSerum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients
Author(s) -
Kasturi Banerjee,
Michael P. Motley,
Elizabeth DiagoNavarro,
Bettina C. Fries
Publication year - 2021
Publication title -
msphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.749
H-Index - 39
ISSN - 2379-5042
DOI - 10.1128/msphere.01335-20
Subject(s) - klebsiella pneumoniae , antibody , microbiology and biotechnology , phagocytosis , serotype , titer , immunoglobulin g , medicine , immunology , biology , escherichia coli , biochemistry , gene
Carbapenem-resistantKlebsiella pneumoniae is a rapidly emerging public health threat that can cause fatal infections in up to 50% of affected patients. Due to its resistance to nearly all antimicrobials, development of alternate therapies like antibodies and vaccines is urgently needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom